Zinforo is an antibiotic. It is used to treat adults and children (including newborn babies) who have: - complicated infections of the skin and soft tissue (tissue below the skin). ‘Complicated’ means that the infection is difficult to treat; - community-acquired pneumonia (an infection of the lungs that is caught outside of hospital). Prescribers should consider official guidance on the appropriate use of antibiotics. Zinforo contains the active substance ceftaroline fosamil.
Therapeutic Indication
### Therapeutic indication Zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: - Complicated skin and soft tissue infections (cSSTI) - Community-acquired pneumonia (CAP) Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Therapeutic Area (MeSH)
ATC Code
J01DI02
ATC Item
ceftaroline fosamil
Pharmacotherapeutic Group
Antibacterials for systemic use
Active Substance (Summary)
INN / Common Names
EMA Name
Zinforo
Medicine Name
Zinforo
Aliases
N/A
